LLY vs UNH
By Alex · Tickerpine
Eli Lilly and Company vs UnitedHealth Group Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | UNH |
|---|---|---|
| Price | $1,208.12 | $427.89 |
| Market cap | $1.08T | $388.59B |
| P/E ratio | 42.9 | 32.3 |
| ROE | 107.46% | 12.18% |
| Profit margin | 34.99% | 2.68% |
| Revenue growth | 55.50% | 2.00% |
| Dividend yield | 0.57% | 2.17% |
| Beta | 0.52 | 0.65 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs UNH in plain English
- LLY is the bigger company — about 2.8× the market cap of UNH.
- UNH is cheaper on earnings (P/E 32.3 vs 42.9).
- LLY earns a higher return on equity (107% vs 12%).
- LLY is growing revenue faster (56% vs 2%).
- UNH has the higher dividend yield (2.17% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.